Cathie Wood Is Betting on This AI Stock: Is It a Buy?

Artificial intelligence (AI) is changing the way we do business. Companies are racing to implement it in umpteen different ways, knowing that the most successful will reap immense financial benefits. That's why investors are also searching for the most exciting AI stocks, but picking the right one might not be easy.How about getting some inspiration from famous investors?Cathie Wood, the CEO of Ark Invest, has several AI stocks in her investment management firm's actively managed ETFs. One of them is Recursion Pharmaceuticals (NASDAQ: RXRX), a company looking to use AI to revolutionize the drug development process. Should investors follow Cathie Wood's lead?Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool